In 2001, it was sold at a price of $ 40, and is currently being sold at a price of $ 40,000. The analogue of this drug is sold in Canada for $ 33, in Europe – at the same adequate price. It is noteworthy that Mallinckrodt owns the rights to sell the Canadian drug in the US, but does not sell it.
The drug is needed for children who are overtaken by infantile spasms (West syndrome) – convulsions characterized by sudden flexion of the trunk forward, flexion or extension of the arms, stretching or flexing the legs. They last only a few seconds, but can be repeated many times a day, manifested in children less than a year old.
Mallinckrodt noted that the price increase occurred before they acquired Questcor pharmaceuticals, which produces this drug.